SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-20-013862
Filing Date
2020-11-16
Accepted
2020-11-16 07:00:26
Documents
51
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 6-K prqr-20200930x6k.htm 6-K 21171
2 EX-99.1 prqr-20200930ex9919c6559.htm EX-99.1 584153
3 EX-99.2 prqr-20200930ex992d07326.htm EX-99.2 565327
  Complete submission text file 0001558370-20-013862.txt   2787519

Data Files

Seq Description Document Type Size
4 EX-101.INS prqr-20200930.xml EX-101.INS 254655
5 EX-101.SCH prqr-20200930.xsd EX-101.SCH 39212
6 EX-101.CAL prqr-20200930_cal.xml EX-101.CAL 36838
7 EX-101.DEF prqr-20200930_def.xml EX-101.DEF 63419
8 EX-101.LAB prqr-20200930_lab.xml EX-101.LAB 254156
9 EX-101.PRE prqr-20200930_pre.xml EX-101.PRE 163710
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 201313606
SIC: 2834 Pharmaceutical Preparations